These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 228312)

  • 1. Prolactin-lowering effect of nomifensine in the rat.
    Cocchi D; Locatelli V; Picciolini E; Genazzani AR; Müller EE
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):38-43. PubMed ID: 228312
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of dopamine in the anterior pituitary as an index of tuberoinfundibular dopaminergic function.
    Apud J; Cocchi D; Iuliano E; Casanueva F; Müller EE; Racagni G
    Brain Res; 1980 Mar; 186(1):226-31. PubMed ID: 6244059
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
    Cocchi D; Novelli A; Ganzetti I; Müller EE
    Gerontology; 1984; 30(6):345-9. PubMed ID: 6519436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nomifensine and body temperature of the rat: interaction with reserpine, chlorpromazine and amphetamine].
    Puche E; Mundo A; García Morillas M; Baeyens JM; Bolaños J
    Arch Farmacol Toxicol; 1979 Aug; 5(2):123-32. PubMed ID: 533317
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine reuptake inhibitors and dopamine releasers: differential effect on plasma prolactin in the rat.
    Cella S; Apud J; Racagni G; Müller EE
    Pharmacol Res Commun; 1982 Oct; 14(9):839-49. PubMed ID: 7178213
    [No Abstract]   [Full Text] [Related]  

  • 6. Nomifensine and central monoamine neurons: histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1977; 29(5):509-19. PubMed ID: 145591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prolactin secretion by nomifensine in man.
    Masala A; Alagna S; Devilla L; Delitala G; Rovasio PP
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):237-41. PubMed ID: 6771065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of two indirectly acting dopamine agonists on prolactin secretion in normo- and hyperprolactinemic subjects: comparison with the effect of nomifensine.
    Camanni F; Genazzani AR; de Leo V; Molinatti GM; Campagnoli C; Cocchi D; Müller EE
    Neuroendocrinology; 1981 Nov; 33(5):300-5. PubMed ID: 7301051
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of nomifensine on dopaminergic transmission in healthy volunteers evaluated by means of the electroretinographic technique.
    Fornaro P; Dell'Osso L; Perossini M; Placidi GF; Castrogiovanni P
    Acta Neurol (Napoli); 1984 Feb; 6(1):5-10. PubMed ID: 6324550
    [No Abstract]   [Full Text] [Related]  

  • 10. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differences in the mechanisms of the stimulant and antidepressive effects of nomifensine].
    Chermat R; Poncelet M; Simon P
    J Pharmacol; 1985; 16(1):7-13. PubMed ID: 2860270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine.
    Raiteri M; Cerrito F; Cervoni AM; Levi G
    J Pharmacol Exp Ther; 1979 Feb; 208(2):195-202. PubMed ID: 216794
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopaminergic regulation of the estrogen-induced glandular kallikrein in the rat anterior pituitary.
    Powers CA; Hatala MA
    Neuroendocrinology; 1986; 44(4):462-9. PubMed ID: 3029615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroids interact with dopamine at the hypothalamic and pituitary levels to modulate prolactin secretion.
    Labrie F; Ferland L; Denizeau F; Beaulieu M
    J Steroid Biochem; 1980 Jan; 12():323-30. PubMed ID: 7421220
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of hypothalamic dopaminergic function by neuropharmacologic means in aged women.
    Cocchi D; Castoldi C; Locatelli S; Novelli A; Colombo AM; Tammaro A; Müller EE
    J Neural Transm; 1985; 64(3-4):199-210. PubMed ID: 3003250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubero-infundibular dopaminergic function in cirrhotic patients: evaluation by nomifensine and domperidone.
    Monza GC; Lampertico M; Locatelli S; Sali L; Cocchi D
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):315-20. PubMed ID: 6880568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of central acting drugs on serum and pituitary prolactin levels in rats.
    Lu KH; Amenomori Y; Chen CL; Meites J
    Endocrinology; 1970 Oct; 87(4):667-72. PubMed ID: 5453281
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopaminergic and serotonergic control of neuroendocrine function.
    Gudelsky GA; Simonovic M; Meltzer HY
    Monogr Neural Sci; 1984; 10():85-102. PubMed ID: 6142416
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of the dopaminergic agonists bromocriptine, piribedil and nomifensine on the sympathetic neural transmission in the nictitating membrane of the cat.
    György L; Dóda M
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):4-11. PubMed ID: 6261705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.